Stocktoria
Inhibikase Therapeutics, Inc. IKT
Nasdaq · XNAS · stock · Biological Products, (No Diagnostic Substances) · website · IPO 2020-12-23
Inhibikase Therapeutics, Inc. institutional holders (13F)
| Investor | Shares | Value |
|---|---|---|
| MILLENNIUM MANAGEMENT LLC | 2,928,077 | $4.9M |
| CITADEL ADVISORS LLC | 1,102,585 | $1.9M |
| TWO SIGMA INVESTMENTS, LP | 847,611 | $1.4M |
| AQR CAPITAL MANAGEMENT LLC | 172,013 | $288,982 |
| Point72 Asset Management, L.P. | 40,383 | $67,843 |
| RENAISSANCE TECHNOLOGIES LLC | 16,500 | $27,720 |
Source: SEC EDGAR filings · CIK 0001750149 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.